Saturday, 31 October 2026European Markets

AUBAY And LINEDATA SERVICES Have A High Dividend Yield And Return On Equity In The Technology Sector.

Loading stream...

(vianews) - aubay (aub.pa) is among this list of stock assets with the highest dividend rate and return on equity on the technology sector.

financial asset price forward dividend yield return on equity
aubay (aub.pa) €35.85 3.23% 13.05%
linedata services (lin.pa) €68.40 2.46% 24.06%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. aubay (aub.pa)

3.23% forward dividend yield and 13.05% return on equity

aubay société anonyme provides application services in belgium, luxembourg, spain, portugal, italy, france, and the united kingdom. the company offers consulting; digital experience services, such as service design thinking/design strategist, ux design/ux digital designer, ui design/ui digital designer, and product management/product owner digital; smart automation/intelligent process automation services, including audit and business process optimization, process mining, ocr and intelligent document processing, natural language processing (nlp) and natural language understanding (nlu), and machine learning/deep learning; and agility services, such as maturity audit, training and support, and operational agility. it also provides application services; data and analytics services comprising data governance, data platform, data science, and dataviz and business intelligence; cybersecurity services, such as governance, risk, compliance consulting, project and development security, and secure architecture, as well as audits/pentesting; cloud infrastructure; and test and automation services, including it and business testing, method and tools consulting, and performance testing. the company serves banking/finance, insurance/social security, telecoms/media/gaming, energy/utilities/health, administration, transportation, and retail/luxury sectors. aubay société anonyme was incorporated in 1944 and is headquartered in boulogne-billancourt, france.

earnings per share

as for profitability, aubay has a trailing twelve months eps of €2.54.

pe ratio

aubay has a trailing twelve months price to earnings ratio of 14.11. meaning, the purchaser of the share is investing €14.11 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.05%.

volatility

aubay's last week, last month's, and last quarter's current intraday variation average was a negative 1.13%, a positive 0.02%, and a positive 1.24%.

aubay's highest amplitude of average volatility was 1.27% (last week), 0.84% (last month), and 1.24% (last quarter).

moving average

aubay's value is way under its 50-day moving average of €41.10 and under its 200-day moving average of €39.68.

dividend yield

according to morningstar, inc., the next dividend payment is on may 17, 2024, the estimated forward annual dividend rate is 1.2 and the estimated forward annual dividend yield is 3.23%.

volume

today's last reported volume for aubay is 2557 which is 68.7% below its average volume of 8171.

more news about aubay.

2. linedata services (lin.pa)

2.46% forward dividend yield and 24.06% return on equity

linedata services s.a. develops, publishes, and distributes financial software in southern europe, northern europe, north america, and asia. it operates through asset management and lending & leasing segments. the company provides solutions for asset managers and servicers, such as order management trading, investment compliance, risk management, and oversights; software for fund accounting, fund oversight, and transfer agency; analytics and data services; reconciliation solution and expense management; and investment data analytics and cognitive investment data management. it also offers solutions for lenders and lessors, such as commercial and syndicated lending, as well as for automotive, consumer, and equipment finance; and digitalization, marketplace, outsourced spreading, professional and hosting, and remarketing services, as well as business process as a service. in addition, the company provides advisory, risk and research, middle and office, and risk services, as well as technology solutions. linedata services s.a. was incorporated in 1998 and is headquartered in neuilly-sur-seine, france.

earnings per share

as for profitability, linedata services has a trailing twelve months eps of €4.03.

pe ratio

linedata services has a trailing twelve months price to earnings ratio of 16.97. meaning, the purchaser of the share is investing €16.97 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 24.06%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, linedata services's stock is considered to be overbought (>=80).

volume

today's last reported volume for linedata services is 211 which is 43.43% below its average volume of 373.

volatility

linedata services's last week, last month's, and last quarter's current intraday variation average was a negative 2.47%, a negative 0.35%, and a positive 1.36%.

linedata services's highest amplitude of average volatility was 2.47% (last week), 1.04% (last month), and 1.36% (last quarter).

more news about linedata services.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com